BioCentury | Jul 18, 2011
Finance

Biotech investor, banker and analyst personnel changes

...Analyst tracks Biren Amin has left as biotechnology and healthcare sector analyst at WJB Capital to join...
BioCentury | Jan 31, 2011
Analyst Picks & Changes

Analyst picks & changes

...see BioCentury, Jan. 24). Elan Corp. plc (NYSE:ELN) Jefferies Corey Davis New Buy 7% $6.92 WJB Capital...
...NYSE:NVS; SIX:NOVN). sanofi-aventis Group (Euronext:SAN; NYSE:SNY) markets Lovenox, a low-molecular weight heparin. Vivus Inc. (NASDAQ:VVUS) WJB Capital...
BioCentury | Jan 3, 2011
Analyst Picks & Changes

Analyst picks & changes

...Russo Upgrade Market outperform (from neutral) -2% $36.40 Leerink Howard Liang Price target Market outperform WJB Capital...
BioCentury | Dec 20, 2010
Analyst Picks & Changes

Analyst Picks & Changes

...Cutler Upgrade Buy (from hold) 152% $34.89 Wedbush Katherine Xu Upgrade Market outperform (from neutral) WJB Capital...
BioCentury | Oct 25, 2010
Analyst Picks & Changes

Analyst picks & changes

...Windley Price target Hold -25% $11.07 Leerink Steve Yoo Downgrade Market perform (from market outperform) WJB Capital...
BioCentury | Oct 18, 2010
Analyst Picks & Changes

Analyst picks & changes

..."Staccato Stumble," A13). Alkermes Inc. (NASDAQ:ALKS) Jefferies David Windley Downgrade Hold (from buy) -7% $14.80 WJB Capital...
BioCentury | Oct 11, 2010
Analyst Picks & Changes

Analyst Picks & Changes

...16% $15.48 Canaccord Adam Cutler Price target Hold Leerink Howard Liang Price target Market outperform WJB Capital...
BioCentury | Mar 8, 2010
Finance

Ebb & Flow

...where he was a managing director and head of biotechnology equity research. Biren Amin joined WJB Capital...
Items per page:
1 - 8 of 8
BioCentury | Jul 18, 2011
Finance

Biotech investor, banker and analyst personnel changes

...Analyst tracks Biren Amin has left as biotechnology and healthcare sector analyst at WJB Capital to join...
BioCentury | Jan 31, 2011
Analyst Picks & Changes

Analyst picks & changes

...see BioCentury, Jan. 24). Elan Corp. plc (NYSE:ELN) Jefferies Corey Davis New Buy 7% $6.92 WJB Capital...
...NYSE:NVS; SIX:NOVN). sanofi-aventis Group (Euronext:SAN; NYSE:SNY) markets Lovenox, a low-molecular weight heparin. Vivus Inc. (NASDAQ:VVUS) WJB Capital...
BioCentury | Jan 3, 2011
Analyst Picks & Changes

Analyst picks & changes

...Russo Upgrade Market outperform (from neutral) -2% $36.40 Leerink Howard Liang Price target Market outperform WJB Capital...
BioCentury | Dec 20, 2010
Analyst Picks & Changes

Analyst Picks & Changes

...Cutler Upgrade Buy (from hold) 152% $34.89 Wedbush Katherine Xu Upgrade Market outperform (from neutral) WJB Capital...
BioCentury | Oct 25, 2010
Analyst Picks & Changes

Analyst picks & changes

...Windley Price target Hold -25% $11.07 Leerink Steve Yoo Downgrade Market perform (from market outperform) WJB Capital...
BioCentury | Oct 18, 2010
Analyst Picks & Changes

Analyst picks & changes

..."Staccato Stumble," A13). Alkermes Inc. (NASDAQ:ALKS) Jefferies David Windley Downgrade Hold (from buy) -7% $14.80 WJB Capital...
BioCentury | Oct 11, 2010
Analyst Picks & Changes

Analyst Picks & Changes

...16% $15.48 Canaccord Adam Cutler Price target Hold Leerink Howard Liang Price target Market outperform WJB Capital...
BioCentury | Mar 8, 2010
Finance

Ebb & Flow

...where he was a managing director and head of biotechnology equity research. Biren Amin joined WJB Capital...
Items per page:
1 - 8 of 8